cefmetazole has been researched along with moxalactam in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (76.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandsch, M; Luckner, P | 1 |
| Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Kanamori, M; Kirikae, T; Kitao, T; Miyoshi-Akiyama, T; Morita, K; Okazaki, M; Sekiguchi, J; Watanabe, N | 1 |
| Imamura, Y; Kodama, T; Matsuura, Y; Miyamoto, K; Murakami, Y; Sewake, H; Takesue, Y; Tsumura, H; Yokoyama, T | 1 |
| Deguchi, K; Fukayama, S; Fukushima, Y; Koguchi, M; Nakane, Y; Nishimura, Y; Oda, S; Sato, K; Tanaka, S; Yokota, N | 1 |
| Metzler, CM; Peters, GR | 1 |
| Kakushi, H; Shike, T; Uchida, K | 1 |
| Haga, T; Miyashita, H; Muraoka, A; Nishiya, H; Nozue, N; Ono, Y; Ueda, Y | 1 |
| Hirai, Y; Imamura, K; Kudo, H; Kumasaka, Y; Makino, I; Miyazawa, T; Nakahata, H; Nakamura, T; Takebe, K | 1 |
| Asari, S; Hayashi, C; Horikawa, M; Kouda, K; Miyai, K; Tsukamoto, H | 1 |
| Hirai, Y; Imamura, K; Kumasaka, Y; Nakahata, H; Senda, H; Suzuki, I; Takebe, K | 1 |
| Hayashi, Y; Nakamura, K; Shimada, J | 1 |
| Miyazawa, K; Takahashi, C | 1 |
| Date, H; Goi, H; Hara, T; Ishii, T; Jinzaki, M; Kasai, T; Matsugami, A; Miyauchi, K; Shindo, H; Watanabe, T | 1 |
| Arai, T; Kato, H; Miyano, T; Nittono, H; Suruga, K | 1 |
| Brogard, JM; Comte, F | 1 |
| Neu, HC | 1 |
| Gaspar, MC; Ponte, MC; Soriano, F | 1 |
| Fujimoto, S; Furuta, I; Harikane, O; Hiromatsu, K; Iimori, M; Kamiki, T; Kodama, J; Kotera, K; Maejima, K; Masutani, T; Matsunaga, K; Miwatani, T; Nishimura, T; Nukina, M; Shimizu, Y; Tabuki, K; Takahashi, M; Takashima, E; Takashima, T; Takeda, Y; Tanaka, M; Yabuuchi, E; Yamanaka, K; Yoshizaki, E | 1 |
| Asahi, Y; Isono, M; Kesado, T; Ueno, K; Watanabe, K | 1 |
| Furukawa, S; Matsuo, K; Tsuzaki, Y; Uete, T | 1 |
| Inamatsu, T; Matsuda, T; Shimada, K; Urayama, K | 1 |
| Shinagawa, N | 1 |
| Harada, K; Iyori, K; Jitsuiki, M; Kanao, Y; Kusumoto, M; Narita, H; Torii, K; Tsunoi, M; Tsuyuki, Y | 1 |
2 review(s) available for cefmetazole and moxalactam
| Article | Year |
|---|---|
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
1 trial(s) available for cefmetazole and moxalactam
| Article | Year |
|---|---|
The effects of cefmetazole and latamoxef on platelet function in healthy human volunteers.
Topics: Adenosine Diphosphate; Adult; Bleeding Time; Blood Platelets; Cefmetazole; Female; Humans; Male; Middle Aged; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Platelet Aggregation Inhibitors; Prothrombin Time | 1989 |
22 other study(ies) available for cefmetazole and moxalactam
| Article | Year |
|---|---|
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Citrobacter freundii; Conjugation, Genetic; DNA Primers; DNA, Bacterial; Enterobacteriaceae Infections; Escherichia coli K12; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Phylogeny; Plasmids; Recombinant Proteins; Sequence Homology, Amino Acid | 2008 |
Beta-lactamase in gram-negative rods: the relationship between penicillinase and R plasmids in gram-negative rods.
Topics: beta-Lactamases; Cefazolin; Cefmetazole; Cefoperazone; Cephalosporinase; Citrobacter; Enterobacter; Escherichia coli; Gram-Negative Bacteria; Klebsiella pneumoniae; Moxalactam; Penicillin G; Penicillinase; Pseudomonas aeruginosa; R Factors; Serratia marcescens | 1990 |
[Determination of the MIC of cefotetan against freshly isolated gram-negative bacilli].
Topics: Cefazolin; Cefmetazole; Cefotetan; Cefoxitin; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Moxalactam | 1989 |
Effects of 1-S replaced and/or decarboxylated latamoxef on rabbit platelet aggregation in vitro.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Carbenicillin; Cefmetazole; Cefotaxime; Cephamycins; In Vitro Techniques; Male; Moxalactam; Platelet Aggregation; Rabbits | 1988 |
[Laboratory and clinical studies of flomoxef].
Topics: Adult; Bacteria; Bacterial Infections; Cefazolin; Cefmetazole; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Escherichia coli; Female; Humans; Infusions, Intravenous; Klebsiella; Male; Middle Aged; Moxalactam | 1987 |
[Free methyltetrazolethiol concentrations in men subjected to intravenous administration of cephems with methyltetrazolethiol].
Topics: Aldehyde Oxidoreductases; Azoles; Biotransformation; Cefmetazole; Cefoperazone; Cephalosporins; Cephamycins; Disulfiram; Humans; Injections, Intravenous; Liver; Liver Cirrhosis; Middle Aged; Moxalactam; Tetrazoles | 1987 |
[Susceptibility of clinical isolates to aztreonam].
Topics: Aztreonam; Cefmetazole; Cefoperazone; Cefotaxime; Cefsulodin; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1987 |
[In vivo antibacterial activity of cefbuperazone. Synergy of cefbuperazone for bactericidal effect with human polymorphonuclear leukocytes].
Topics: Animals; Blood Bactericidal Activity; Cefmetazole; Cefoperazone; Cefotetan; Cephamycins; Escherichia coli; Escherichia coli Infections; Male; Mice; Mice, Inbred ICR; Moxalactam; Neutrophils | 1986 |
Cefmetazole: clinical evaluation of efficacy and safety in Japan.
Topics: Adolescent; Adult; Aged; Aging; Aldehyde Oxidoreductases; Animals; Azoles; Bacterial Infections; Cefmetazole; Cefoperazone; Cephamycins; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dogs; Drug Evaluation; Ethanol; Humans; In Vitro Techniques; Infant; Japan; Macaca fascicularis; Male; Middle Aged; Moxalactam; Rats; Rats, Inbred Strains; Respiratory Tract Infections; Structure-Activity Relationship; Tetrazoles | 1985 |
[Antibacterial activity of cefmenoxime against clinical isolates. Comparative study].
Topics: Ampicillin; Cefazolin; Cefmenoxime; Cefmetazole; Cefotaxime; Cephamycins; Escherichia coli; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Proteus; Proteus mirabilis; Serratia marcescens | 1985 |
[Antibacterial activity of MT-141 against anaerobic bacteria].
Topics: Animals; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Cefmetazole; Cephamycins; Clostridium Infections; Clostridium perfringens; Drug Resistance, Microbial; Mice; Moxalactam | 1984 |
Antibiotic excretion into the bile after hepatic-portojejunostomy in biliary atresia.
Topics: Bile; Bile Ducts; Cefmetazole; Cephalosporins; Cephamycins; Child; Child, Preschool; Humans; Infant; Jejunum; Liver; Moxalactam | 1983 |
The in vitro responses of Bacteroides fragilis to Moxalactam, Cefotaxime, Cefmetazole, Josamycin and erythromycin.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cefmetazole; Cefotaxime; Cephamycins; Erythromycin; Leucomycins; Microbial Sensitivity Tests; Moxalactam | 1982 |
[The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Topics: Bacteria; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacter; Haemophilus influenzae; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Proteus; Streptococcus pneumoniae | 1983 |
Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamases; Cefmetazole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam | 1984 |
[Comparison of in vitro activity of first, second and third generation cephem antibiotics against various pathogens isolated from clinical materials in 1983].
Topics: Cefazolin; Cefmetazole; Cephalexin; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Escherichia coli; Humans; Moxalactam; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 1984 |
Bleeding secondary to vitamin K deficiency in patients receiving parenteral cephem antibiotics.
Topics: Aged; Bacteria; Blood Coagulation Factors; Cefazolin; Cefmetazole; Cefoperazone; Ceftazidime; Cephalosporins; Cephamycins; Female; Hemorrhage; Humans; Injections, Intravenous; Intestines; Male; Moxalactam; Vitamin K; Vitamin K Deficiency | 1984 |
Comparative pharmacokinetics of ceftriaxone, cefmetazole and moxalactam during abdominal surgery.
Topics: Anti-Bacterial Agents; Cefmetazole; Ceftriaxone; Humans; Injections, Intravenous; Intraoperative Care; Intraoperative Period; Kinetics; Metabolic Clearance Rate; Moxalactam | 1989 |
In vitro efficacy of cephamycins against multiple extended-spectrum β-lactamase-producing Klebsiella pneumoniae, Proteus mirabilis, and Enterobacter cloacae isolates from dogs and cats.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cat Diseases; Cats; Cefmetazole; Cephamycins; Dog Diseases; Dogs; Enterobacter cloacae; Enterobacteriaceae; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Proteus mirabilis | 2023 |